Epigral Ltd. Cash Flow Conversion Efficiency

Latest as of September 2025: 0.127x

Epigral Ltd. cash flow conversion efficiency. Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has a cash flow conversion efficiency ratio of 0.127x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.67 Billion ≈ $28.91 Million USD) by net assets (Rs21.01 Billion ≈ $227.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Epigral Ltd. (2015–2026)

Cash flow conversion efficiency of Epigral Ltd. from 2015 to 2026. This chart illustrates how Epigral Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View EPIGRAL stock price and chart for real-time trading data and today's change.

Epigral Ltd. Cash Flow Conversion Ratio Explained

Epigral Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Epigral Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Epigral Ltd. ranked by their cash flow conversion efficiency. Also see Epigral Ltd. stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Tianshui Zhongxing Bio-technology Co Ltd
SHE:002772
0.058x
Shenzhen TVT Digital Technology Co Ltd
SHE:002835
0.032x
Shanghai Guangdian Electric Group Co Ltd
SHG:601616
-0.002x
Stx Engine
KO:077970
0.003x
Industrial Logistics Properties Trust
NASDAQ:ILPT
0.018x
Topkey Corp
TW:4536
0.026x
JOONGANG DNM Co.Ltd
KQ:051980
0.004x
JinGuan Electric Co Ltd
SHG:688517
0.020x

Annual Cash Flow Conversion Efficiency for Epigral Ltd. (2015–2026)

The table below shows the annual cash flow conversion efficiency of Epigral Ltd. from 2015 to 2026. Review Epigral Ltd. free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs22.21 Billion
≈ $240.24 Million
Rs3.88 Billion
≈ $41.92 Million
0.174x -24.57%
2025-03-31 Rs19.05 Billion
≈ $205.97 Million
Rs4.41 Billion
≈ $47.64 Million
0.231x -27.04%
2024-03-31 Rs12.54 Billion
≈ $135.63 Million
Rs3.98 Billion
≈ $43.00 Million
0.317x -45.86%
2023-03-31 Rs10.69 Billion
≈ $115.62 Million
Rs6.26 Billion
≈ $67.72 Million
0.586x +49.81%
2022-03-31 Rs7.26 Billion
≈ $78.51 Million
Rs2.84 Billion
≈ $30.69 Million
0.391x +16.69%
2021-03-31 Rs6.84 Billion
≈ $73.99 Million
Rs2.29 Billion
≈ $24.79 Million
0.335x +18.71%
2020-03-31 Rs5.83 Billion
≈ $63.10 Million
Rs1.65 Billion
≈ $17.81 Million
0.282x -46.78%
2019-03-31 Rs4.93 Billion
≈ $53.29 Million
Rs2.61 Billion
≈ $28.26 Million
0.530x +22.00%
2018-03-31 Rs5.17 Billion
≈ $55.95 Million
Rs2.25 Billion
≈ $24.32 Million
0.435x +13.58%
2017-03-31 Rs3.62 Billion
≈ $39.12 Million
Rs1.38 Billion
≈ $14.97 Million
0.383x -8.46%
2016-03-31 Rs2.95 Billion
≈ $31.92 Million
Rs1.23 Billion
≈ $13.35 Million
0.418x -17.91%
2015-03-31 Rs2.20 Billion
≈ $23.82 Million
Rs1.12 Billion
≈ $12.13 Million
0.509x --

About Epigral Ltd.

NSE:EPIGRAL India Chemicals
Market Cap
$429.33 Million
Rs39.70 Billion INR
Market Cap Rank
#12739 Global
#640 in India
Share Price
Rs920.20
Change (1 day)
+0.81%
52-Week Range
Rs810.45 - Rs1670.10
All Time High
Rs2344.35
About

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power pl… Read more